By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tecan has licensed molecular diagnostics intellectual property from Enigma Diagnostics that it will use to pursue development of an integrated diagnostics solution with another partner.

The Swiss lab technologies developer said today that the license covers IP that is used in Enigma's automated point-of-care molecular diagnostic system, the Enigma ML.

Financial terms of the license agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.